[关键词]
[摘要]
摘 要:目的 以壳聚糖为载体制备红景天苷壳聚糖纳米粒(SA-CS-NPs)并考察其体外释药特性。方法 采用溶剂扩散-离子交联法制备SA-CS-NPs,考察其粒径分布和形态,并对SA-CS-NPs 的包封率、载药量及其体外释药特性进行研究。结果 所制得的SA-CS-NPs 呈球形或类球形,平均粒径为(247.5±23.8)nm(n=3),Zeta 电位为(23.4±2.7)mV(n=3),多分散指数(PDI)为0.265±0.071(n=3);平均包封率为(70.15±1.60)%,平均载药量为(14.03±0.32)%(n=3);24 h 累积释放达85%以上。结论 溶剂扩散-离子交联法制备SA-CS-NPs 具有合适的粒径和包封率,并能达到缓释效果。
[Key word]
[Abstract]
Abstract: Objective To prepare salidroside-chitosan nanoparticles (SA-CS-NPs) and to evaluate the properties of in vitro drug release. Methods SA-CS-NPs were firstly prepared by microemulsion-ionic crosslinking method. The particle size and polydispersity of SA-CS-NPs were determined and the morphology of nanoparticles was evaluated. The properties of encapsulation efficiency (EE), load efficiency (LE), and in vitro release of SA-CS-NPs were also evaluated using UPLC method. Resluts The nanoparticles were successfully prepared with the spherical shape or para-spherical shape. The mean particle size was (247.5 ± 23.8) nm with the polydispersity index (PDI) of 0.265 ± 0.071, and the Zeta potential was (23.4 ± 2.7) mV (n = 3). The EE was (70.15 ± 1.60)% and the LE was (14.03 ± 0.32)% (n = 3). The cumulative release rate within 24 h of SA-CS-NPs was over 85%. Conclusion SA-CS-NPs are prepared by microemulsion-ionic crosslinking method show an appropriate particle size and EE, and could exhibit sustained release properties in vitro, which could meet the design requirements.
[中图分类号]
[基金项目]
基金项目:中央高校基本科研业务费专项项目(82000239)